KURE vs BIB
Comparison between KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX ETF (KURE, ETF) and PROSHARES ULTRA NASDAQ BIOTECHNOLOGY (BIB, ETF).
5-Year PerformanceBIB has outperformed KURE, delivering a return of -2.5% compared to -16.7%
KURE vs BIB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
KURE vs BIB - Holdings Comparison
KURE and BIB have 2 common holdings. Overlap is -0.01%
KURE's top 25 holdings weight is 82.33%. BIB's top 25 holdings weight is 71.80%.
| Rank | KURE | BIB |
|---|---|---|
| #1 | BEONE MEDICINES LTD ORDINARY SHARES (n/a) - 8.96% | NASDAQ BIOTECHNOLOGY INDEX SWAP (n/a) - 13.88% |
| #2 | WUXI BIOLOGICS (CAYMAN) INC (n/a) - 8.37% | CASH (n/a) - 11.38% |
| #3 | INNOVENT BIOLOGICS INC (n/a) - 8.34% | PROSHARES GENIUS MONEY MARKET ETF (IQMM) - 6.96% |
| #4 | WUXI APPTEC CO LTD CLASS A (n/a) - 5.75% | GILEAD SCIENCES INC (GILD) - 4.75% |
| #5 | JIANGSU HENGRUI PHARMACEUTICALS CO LTD CLASS A (n/a) - 4.38% | VERTEX PHARMACEUTICALS INC (VRTX) - 4.64% |
| #6 | AKESO INC ORDINARY SHARES (n/a) - 4.36% | AMGEN INC (AMGN) - 4.58% |
| #7 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD CLASS A (n/a) - 4.34% | REGENERON PHARMACEUTICALS INC (REGN) - 3.39% |
| #8 | CSPC PHARMACEUTICAL GROUP LTD (n/a) - 3.92% | CTE PROSHARES TRUST M (n/a) - 3.22% |
| #9 | SINO BIOPHARMACEUTICAL LTD (n/a) - 3.55% | ALNYLAM PHARMACEUTICALS INC (ALNY) - 2.02% |
| #10 | WUXI APPTEC CO LTD (n/a) - 3.55% | REVOLUTION MEDICINES INC ORDINARY SHARES (RVMD) - 1.58% |
| #11 | HANSOH PHARMACEUTICAL GROUP CO LTD (n/a) - 2.85% | BIOGEN INC (BIIB) - 1.46% |
| #12 | SHANGHAI UNITED IMAGING HEALTHCARE CO LTD CLASS A (n/a) - 2.50% | UNITED THERAPEUTICS CORP (UTHR) - 1.30% |
| #13 | 3SBIO INC SHS UNITARY 144A/REG S (n/a) - 2.37% | INSMED INC (INSM) - 1.21% |
| #14 | YUNNAN BAIYAO GROUP CO LTD CLASS A (n/a) - 2.26% | ROYALTY PHARMA PLC CLASS A (RPRX) - 1.19% |
| #15 | AIER EYE HOSPITAL GROUP CO LTD CLASS A (n/a) - 2.17% | ARGENX SE ADR (ARGX) - 1.18% |
| #16 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO LTD CLASS A (n/a) - 1.93% | ILLUMINA INC (ILMN) - 1.14% |
| #17 | SINOPHARM GROUP CO LTD (n/a) - 1.69% | ROIVANT SCIENCES LTD ORDINARY SHARES (ROIV) - 1.09% |
| #18 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO LTD CLASS H SHARES (n/a) - 1.65% | INCYTE CORP (INCY) - 0.99% |
| #19 | LEGEND BIOTECH CORP ADR (LEGN) - 1.49% | VIATRIS INC (VTRS) - 0.96% |
| #20 | SICHUAN KELUN PHARMACEUTICAL CO LTD CLASS A (n/a) - 1.44% | MODERNA INC (MRNA) - 0.95% |
| #21 | WUXI XDC CAYMAN INC (n/a) - 1.40% | GUARDANT HEALTH INC (GH) - 0.81% |
| #22 | SICHUAN BIOKIN PHARMACEUTICAL CO LTD CLASS A (n/a) - 1.35% | NASDAQ BIO INDEX SWAP (n/a) - 0.81% |
| #23 | HUADONG MEDICINE CO LTD CLASS A (n/a) - 1.30% | NEUROCRINE BIOSCIENCES INC (NBIX) - 0.80% |
| #24 | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD CLASS A (n/a) - 1.23% | ASCENDIS PHARMA AS (ASND) - 0.76% |
| #25 | SHANGHAI PHARMACEUTICALS HOLDING CO LTD CLASS A (n/a) - 1.18% | JAZZ PHARMACEUTICALS PLC (JAZZ) - 0.75% |
| Total Holdings | 50 | 260 |
KURE vs BIB - Historical Returns
Returns include dividend reinvestment.
KURE vs BIB - Annual Returns (2010 - 2026)
Returns include dividend reinvestment.
| Year | KURE | BIB |
|---|---|---|
| 2026 | -16.10% | -1.21% |
| 2025 | +27.81% | +57.12% |
| 2024 | -15.76% | -13.29% |
| 2023 | -18.49% | +0.43% |
| 2022 | -24.65% | -29.88% |
| 2021 | -16.25% | -4.77% |
| 2020 | +65.68% | +41.55% |
| 2019 | +36.17% | +43.60% |
| 2018 | -30.07% | -28.47% |
| 2017 | N/A | +35.43% |
| 2016 | N/A | -40.15% |
| 2015 | N/A | +11.86% |
| 2014 | N/A | +66.93% |
| 2013 | N/A | +144.02% |
| 2012 | N/A | +64.72% |
| 2011 | N/A | +13.41% |
| 2010 | N/A | +0.29% |
KURE vs BIB Drawdown Comparison
The maximum drawdown for KURE was -68.45%, occurring on Jul 8, 2024. This drawdown has not yet recovered.
The maximum drawdown for BIB was -67.24%, occurring on Jun 27, 2016. Recovery took 1389 trading sessions.
The current KURE drawdown is -62.61%. The current BIB drawdown is -27.48%.
| Rank | KURE | BIB |
|---|---|---|
| #1 | -68.45% Feb 17, 2021 - Jul 8, 2024 | -67.24% Jul 20, 2015 - Jan 25, 2021 |
| #2 | -45.89% Jun 6, 2018 - Jun 19, 2020 | -66.19% Feb 8, 2021 - Apr 8, 2025 |
| #3 | -12.27% Aug 5, 2020 - Dec 17, 2020 | -40.88% May 12, 2011 - Jan 18, 2012 |
| #4 | -8.47% Apr 10, 2018 - May 10, 2018 | -39.01% Feb 25, 2014 - Sep 24, 2014 |
| #5 | -7.99% Jan 25, 2021 - Feb 9, 2021 | -36.30% Apr 15, 2010 - Dec 17, 2010 |
| #6 | -6.66% Jul 15, 2020 - Jul 31, 2020 | -24.73% Oct 5, 2012 - Mar 1, 2013 |
| #7 | -6.39% Mar 20, 2018 - Apr 4, 2018 | -20.33% May 14, 2013 - Jul 11, 2013 |
| #8 | -5.64% Feb 2, 2018 - Feb 26, 2018 | -17.74% Mar 20, 2015 - Jun 18, 2015 |
| #9 | -2.60% Feb 26, 2018 - Mar 7, 2018 | -17.57% Oct 1, 2013 - Nov 22, 2013 |
| #10 | -2.41% May 10, 2018 - May 15, 2018 | -16.83% Sep 24, 2014 - Oct 23, 2014 |
| #11 | -2.35% Apr 5, 2018 - Apr 10, 2018 | -13.85% Dec 19, 2014 - Jan 20, 2015 |
| #12 | -1.63% Mar 12, 2018 - Mar 19, 2018 | -13.72% Aug 2, 2013 - Sep 5, 2013 |
| #13 | -1.42% May 25, 2018 - Jun 5, 2018 | -13.27% Jan 22, 2014 - Feb 11, 2014 |
| #14 | -1.41% Jan 8, 2021 - Jan 12, 2021 | -13.06% Dec 9, 2014 - Dec 19, 2014 |
| #15 | -1.27% Jun 23, 2020 - Jun 29, 2020 | -11.31% Jun 22, 2015 - Jul 14, 2015 |
Correlation
Correlation between KURE and BIB is 0.64 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Dividend Comparison (2010 - 2026)
KURE vs BIB dividend yield comparison.
| Year | KURE | BIB |
|---|---|---|
| 2026 | 0.00% | 0.01% |
| 2025 | 4.19% | 0.77% |
| 2024 | 1.29% | 1.69% |
| 2023 | 0.64% | 0.07% |
| 2022 | 0.05% | 0.03% |
| 2021 | 14.12% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.25% | 0.00% |
| 2018 | 0.21% | 0.00% |
| 2010 | 0.00% | 0.15% |
Select Stocks to Compare
More Comparisons
Compare with similar stocks